Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrimson Tide Regulatory News (TIDE)

Share Price Information for Crimson Tide (TIDE)

Share Price is delayed by 15 minutes
Get Live Data
92.50    5.00 (5.71%)
Bid:
90.00
Ask:
95.00
Spread: 5.00 (5.556%)
Market Cap: £6.08m
TIDE Live PriceLast checked at - London Stock Exchange

Intraday Crimson Tide Share Chart

Technology provider for study on ageing

7 Apr 2010 07:00

RNS Number : 7582J
Crimson Tide PLC
07 April 2010
 



Crimson Tide Plc

("Crimson Tide" or the "Company")

CRIMSON TIDE TECHNOLOGY KEEPS IRISH GOVERNMENT PROJECT SECURE

Crimson Tide, the mobile software technologies company, is pleased to announce that a ten year study initiated by the Irish Government to ensure that the needs of its older people are met, is utilising an advanced mobile system developed by the Company to guarantee security and confidentiality.

 TILDA (The Irish LongituDinal Study on Ageing) was launched by Minister for Health Mary Harney in November 2006, to study a representative sample of at least 8,000 people, aged 50 years and over and resident in Ireland. It charts their health, social and economic circumstances over a 10-year period.

The study is being carried out across the whole of Ireland by Trinity College Dublin in collaboration with a panel of scientific researchers and international scientists with expertise in various fields of ageing. Crimson Tide's system ensures this operation is carried out in a secure and confidential manner using mobile portable technology. 

The application is centred around the Motorola MC55 hand held device and requires the user to identify and capture each respondent's details. It enables the user to move through a series of screens, adding additional data relevant to the project, as they proceed. 

 The system uses real time GPRS data transfer to ensure that records are updated immediately after each visit, and the hand held device interacts with a number of application-based tests carried out on a laptop computer. All information gathered is kept strictly confidential and used only for research purposes.

Says Dr Hilary Cronin, Medical Director for TILDA: "Crimson Tide is an exceptional company to work with and I cannot recommend them highly enough. Their people are incredibly efficient and so pleasant to deal with. They spent time ensuring that our technology interfaces were user friendly and intuitive. Our initially 'techno-phobic' research nurses now love their PDA's and can't imagine collecting data without them! It has significantly improved the way we conduct our clinical research. Their technologies are now an integral part of our study and I look forward to working with them again in the future."

Crimson Tide Director Laurence Darcy says: "It has been a privilege to work on this study with Trinity College Dublin to develop a state-of-the art mobile data solution. We are working on a range of solutions in the healthcare sector and expect to have more innovative solutions coming to the market this year."

- ends -

For further information, contact:

Crimson Tide plc

Barrie Whipp, Executive Chairman

 

01892 542 444

Threadneedle Communications

Graham Herring/Josh Royston

 

020 7653 9850

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAXQLFBBZFXBBD
Date   Source Headline
24th Jun 20244:48 pmRNSForm 8.3 - Crimson Tide Plc
24th Jun 202411:55 amRNSForm 8.5 (EPT/RI)
21st Jun 202412:45 pmRNSOffer update and possible cash offer
20th Jun 20241:38 pmRNSForm 8.3 - Crimson Tide PLC
18th Jun 20245:08 pmRNSForm 8.3 - Crimson Tide Plc
18th Jun 20244:24 pmRNSForm 8.3 - Crimson Tide Plc
18th Jun 20243:00 pmRNSForm 8.3 - Crimson Tide PLC
17th Jun 202411:55 amRNSForm 8.5 (EPT/RI) - Crimson Tide PLC
14th Jun 20246:11 pmRNSForm 8.3 - Crimson Tide PLC
14th Jun 20242:17 pmRNSForm 8.3 - CRIMSON TIDE PLC
14th Jun 20241:10 pmRNSForm 8.3 - Crimson Tide PLC
13th Jun 20247:00 amRNSForm 8 (OPD) - Crimson Tide plc
12th Jun 20245:20 pmRNSForm 8.3 - Crimson Tide PLC
11th Jun 20246:15 pmRNSForm 8.3 - Checkit plc - Amendment
11th Jun 20246:14 pmRNSForm 8.3 - Crimson Tide plc - Amendment
6th Jun 202412:22 pmRNSForm 8.3 - CRIMSON TIDE PLC
5th Jun 20245:07 pmRNSForm 8.3 - Crimson Tide PLC
5th Jun 20243:26 pmGNWForm 8.3 - [CRIMSON TIDE PLC - Opening Disclosure - 04 06 2024] - (CGWL)
5th Jun 20243:09 pmGNWForm 8.3 - Crimson Tide Plc
5th Jun 20241:48 pmGNWForm 8.3 - Crimson Tide plc
5th Jun 202410:46 amRNSForm 8.5 (EPT/NON-RI) - Crimson Tide PLC
5th Jun 202410:20 amRNSResponse to Possible Offer Announcement
4th Jun 20245:06 pmRNSRule 2.9 Announcement
4th Jun 20247:00 amRNSPossible Offer for Crimson Tide plc
3rd Jun 202410:15 amRNSPosting of Annual Report and Notice of AGM
22nd May 20247:00 amRNSBoard Changes
17th Apr 202410:05 amRNSBoard Changes
17th Apr 20247:00 amRNSPreliminary Results to 31 December 2023
23rd Jan 20247:00 amRNSTrading Update
28th Nov 20237:00 amRNSTrading Update
31st Oct 202311:45 amRNSResult of GM, Share Consolidation & TVR
10th Oct 20237:00 amRNSContract increases and extensions
6th Oct 20237:00 amRNSFurther re: Proposed Share Consolidation
5th Oct 20237:00 amRNSProposed Share Consolidation
26th Sep 20237:00 amRNSDirector dealing
25th Sep 20237:00 amRNSInterim Results
20th Sep 20237:00 amRNSContract Win
14th Sep 20237:00 amRNSStrengthened Operating Board
20th Jun 20234:20 pmRNSResult of AGM and Statement
31st May 20237:00 amRNSBoard changes
31st May 20237:00 amRNSPosting of Annual Report and Notice of AGM
10th May 20232:10 pmRNSDirectorate Change
4th May 20237:00 amRNSContract Win and Renewals
12th Apr 20237:00 amRNSPreliminary Results
5th Apr 20237:00 amRNSContract Win
1st Mar 20237:00 amRNSNotice of Results and Investor Presentation
7th Feb 20232:00 pmRNSHolding(s) in Company
6th Feb 20233:55 pmRNSHolding(s) in Company
1st Feb 20237:00 amRNSContract Win
18th Jan 20237:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.